Risk estimation for breast cancer development; a clinical perspective (Q34646517)

3 August 2017

1 reference

title

Risk estimation for breast cancer development; a clinical perspective (English)

1 reference

3 August 2017

George H Sakorafas

1

1 reference

PubMed ID

12020673

3 August 2017

Eustathios Krespis

series ordinal

2

1 reference

PubMed ID

12020673

3 August 2017

George Pavlakis

series ordinal

3

1 reference

3 August 2017

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

10

1 reference

3 August 2017

4

1 reference

3 August 2017

183-192

1 reference

3 August 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Recent trends in U.S. breast cancer incidence, survival, and mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Breast cancer risk assessment: Who holds the magic crystal ball?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Identification and management of the woman at increased risk for breast cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Genetic predisposition to breast cancer: a surgical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Reproductive factors and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

1 reference

7 January 2021

Breast cancer prevention: a review of current evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

A review of the epidemiology of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Risk of breast cancer among young women: relationship to induced abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

The woman at increased risk for breast cancer: evaluation and management strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Risk of invasive cancer in women with lobular carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

The clinical significance of pre-invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Management of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Optimal Management of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

The current role of prophylactic mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Contralateral breast cancer: clinical characteristics and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

The genetic epidemiology of second primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Cancer in the contralateral breast after radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Synchronous, bilateral mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Risk of familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

1 reference

7 January 2021

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Prophylactic mastectomy for genetic predisposition to breast cancer: The Proband's story

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Epidemiology, prevention, and early detection of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Practical guide for estimating risk for familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Validation of a breast cancer risk assessment model in women with a positive family history.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Validation of the Gail et al. model for predicting individual breast cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Assessing the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Prophylactic mastectomy; evolving perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Living in a High-Risk Family

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Mammography adherence and psychological distress among women at risk for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900016-6

7 January 2021

10.1016/S0960-7404(02)00016-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12020673